~90% of patients with alpha-1 are undiagnosed2,3
Alpha1-antitrypsin (AAT) deficiency, also known as alpha-1 or genetic COPD, is one of the world's most prevalent, potentially fatal hereditary diseases.3,4
Alpha-1 may be a contributing cause for up to 3% of all COPD cases in the United States.1,3
Screening for alpha-1 is free,* fast, and easy with AlphaID
AlphaID is a fast and easy cheek swab that screens for alpha-1.5 Ruling out alpha-1 as a contributing cause of COPD has never been easier.
Leading clinical organizations recommend screening all patients with COPD for alpha-16-10
Screening of all patients with COPD for alpha-1, regardless of age and smoking history, is recommended by the Global Initiative for Chronic Obstructive Lung Disease (GOLD) and the World Health Organization (WHO), as well as the following organizations